MDWD
MDWD
NASDAQ · Pharmaceuticals

Mediwound Ltd

$14.86
+0.79 (+5.61%)
Financial Highlights (FY 2026)
Revenue
19.20M
Net Income
-27,039,001
Gross Margin
19.2%
Profit Margin
-140.8%
Rev Growth
-13.8%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 19.2% 19.2% 36.4% 36.4%
Operating Margin -149.0% -134.1% 13.9% 16.0%
Profit Margin -140.8% -133.8% 15.0% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 19.20M 22.28M 84.88M 71.76M
Gross Profit 3.69M 4.28M 30.88M 26.11M
Operating Income -28,608,587 -29,876,686 11.80M 11.51M
Net Income -27,039,001 -28,237,527 12.73M 10.88M
Gross Margin 19.2% 19.2% 36.4% 36.4%
Operating Margin -149.0% -134.1% 13.9% 16.0%
Profit Margin -140.8% -133.8% 15.0% 15.2%
Rev Growth -13.8% -13.8% +19.4% +16.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 15.31M 15.31M 126.77M 98.08M
Total Equity 76.15M 76.15M 68.95M 72.24M
D/E Ratio 0.20 0.20 1.84 1.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,341,725 -30,139,984 16.15M 13.06M
Free Cash Flow 13.25M 12.55M